Cardiovascular Disease Doctors in Flourtown, PA Accepting Medicare

8 Cardiovascular Disease doctors found. Showing 1 - 8

Thomas F Diaz, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1722 Bethlehem Pike, Flourtown, PA 19031 Phone: 215-233-9700    Fax: 215-233-9710

Dr. Gilbert L Zuckerman, M.D. Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1722 Bethlehem Pike, Chestnut Hill Cardiology Ltd, Flourtown, PA 19031 Phone: 215-233-9700    Fax: 215-233-9710

Ram Y. Gordon, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1722 Bethlehem Pike, Flourtown, PA 19031 Phone: 215-233-9700    Fax: 215-233-9710

Dr. David E Chinn, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1722 Bethlehem Pike, Flourtown, PA 19031 Phone: 215-233-9700    Fax: 215-233-9710

Dr. Raphael T Bloomgarden, M.D. Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1722 Bethlehem Pike, Chestnut Hill Cardiology Ltd, Flourtown, PA 19031 Phone: 215-233-9700    Fax: 215-233-9710

Dr. David M Rodgers, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1722 Bethlehem Pike, Flourtown, PA 19031 Phone: 215-233-9700    Fax: 215-233-9710

Dr. Alison E Branigan, M.D. Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1722 Bethlehem Pike, Chestnut Hill Cardiology Ltd, Flourtown, PA 19031 Phone: 215-233-9700    Fax: 215-233-9710

Natasha Fonseka, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1722 Bethlehem Pike, Flourtown, PA 19031 Phone: 215-233-9700    Fax: 215-233-9710

News Archive

Invitae launches new education program to increase awareness of genetic testing for hereditary cancer

A new survey released today shows 73 percent of Americans are aware of genetic testing for hereditary cancers – a significant increase over just a few years ago. Previous research found that in 2010 less than half of the Americans surveyed said they were aware of genetic testing. Dubbed the "Angelina Jolie Effect," the current data highlight the far-reaching impact of Angelina Jolie's public discussion of genetic testing for hereditary cancer.

New study improves safety conditions during laparoscopic operations to avoid contagion by COVID-19

A team of researchers from the Department of Medicine of the Universitat Jaume I and health professionals from the Multidisciplinary Unit of Abdominopelvic Oncological Surgery together with the rest of the services that make up the surgical block of the General University Hospital of Castellón, have carried out a study (CovidLap) that has improved safety conditions during laparoscopic interventions to avoid contagion by COVID-19 among both health personnel and patients.

Seattle Genetics submits brentuximab vedotin BLA to FDA for treatment of ALCL, Hodgkin lymphoma

Seattle Genetics, Inc. announced today that it has submitted a Biologics License Application to the U.S. Food and Drug Administration for the use of brentuximab vedotin in relapsed or refractory Hodgkin lymphoma and relapsed or refractory systemic anaplastic large cell lymphoma.

ImmunoGen's clinical data on IMGN901 and SAR3419 to be presented at ASCO 2011

ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced that favorable clinical data on two ImmunoGen-created TAP compounds - IMGN901 and SAR3419 - are being presented at the ASCO 2011 Annual Meeting taking place in Chicago, IL, June 4-8, 2011.

Read more Medical News

› Verified 2 days ago